These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. [Pulmonary tuberculosis and primary bacterial resistance to antibacillary drugs]. Cazes M Torax; 1967 Dec; 16(4):222-30. PubMed ID: 5620686 [No Abstract] [Full Text] [Related]
66. [Clinical course of pulmonary tuberculosis in adults with resistance of tubercle bacilli to classical drugs]. Czkwianianc M Gruzlica; 1965 Jul; 33(7):587-92. PubMed ID: 5849565 [No Abstract] [Full Text] [Related]
67. [Condition of pulmonary vessels in tuberculotic patients of advanced age]. Sokolov SB; Basiev ZG; Gorislavets II Probl Tuberk; 1972; 50(8):17-20. PubMed ID: 5055491 [No Abstract] [Full Text] [Related]
68. [Advances in the treatment of pulmonary tuberculosis in children]. Alcaide Megias J; Altet Gómez MN An Esp Pediatr; 1983 Sep; 19 Suppl 19():12-7. PubMed ID: 6419658 [No Abstract] [Full Text] [Related]
70. [Clinical research on the use of morphazinamide in pulmonary tuberculosis]. Jancík E Minerva Med; 1965 Sep; 56(71):2905-10. PubMed ID: 5322274 [No Abstract] [Full Text] [Related]
71. [Problems in the treatment of patients with pulmonary tuberculosis]. Chukanov VI Probl Tuberk; 1997; (4):17-9. PubMed ID: 9333807 [TBL] [Abstract][Full Text] [Related]
72. Initial drug resistance pattern in new cases of pulmonary tuberculosis. Chandramuki A; Nagarathna S; Veena Kumari HB; Buggi S J Assoc Physicians India; 2008 Mar; 56():202. PubMed ID: 18697641 [No Abstract] [Full Text] [Related]
73. Prevention and modern treatment of tuberculosis. J Med Soc N J; 1982 Mar; 79(3):237-42. PubMed ID: 6953257 [No Abstract] [Full Text] [Related]
74. [Clinical importance of primary resistance to major drugs in pulmonary tuberculosis patients]. Balestrino E; Pio A Torax; 1967 Jun; 16(2):64-9. PubMed ID: 5614163 [No Abstract] [Full Text] [Related]
75. [Primary resistance to major antitubercular drugs in patients with recently discovered pulmonary tuberculosis in the yea.s 1961-1969]. Zduńczyk-Pawelek H; Antosiewicz A; Blitek-Golc D Gruzlica; 1971 Feb; 39(2):89-93. PubMed ID: 5551351 [No Abstract] [Full Text] [Related]
76. [Current views on treatment of tuberculosis. Symposium (VI). Current resistance problems in Uppsala patients]. Hillerdal O Lakartidningen; 1966 May; 63(18):1757-8. PubMed ID: 5917520 [No Abstract] [Full Text] [Related]
77. [Reasons for failures in chemotherapy of tuberculosis]. Dissmann E Beitr Klin Erforsch Tuberk Lungenkr; 1968; 138(1):17-24. PubMed ID: 5728639 [No Abstract] [Full Text] [Related]
78. [Significance of mycobacterial drug resistance in pulmonary tuberculosis surgery]. Repin IuM; Avetisian AO; El'kin AV; Otten TF; Riasnianskaia TE; Trofimov MA Probl Tuberk; 2001; (9):6-10. PubMed ID: 11858098 [TBL] [Abstract][Full Text] [Related]
79. [Results of treatment of pulmonary tuberculosis in aged patients (after 6-years of observation)]. Smaga M; Cyganiewicz E; Mysakowska H Gruzlica; 1967; 35(11):1181-6. PubMed ID: 6063622 [No Abstract] [Full Text] [Related]
80. [The Mycobacteria Working Group: Investigation of resistance of tuberculosis bacteria in Germany 1991 and 1992]. Urbanczik R Pneumologie; 1994 Jan; 48(1):28-9. PubMed ID: 8153116 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]